Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

The FDA has approved Teal Health's at-home test for HPV detection, which may help expand access to cervical cancer screening ...

Some new glow in the dark technology called Cytalux is helping remove cancer cells. Cytalux is the first and only ...

U.S. health officials are announcing an effort to phase out ingestible fluoride supplements used to strengthen children’s ...

A Boston Duck Tours guide is back at work after a groundbreaking aortic aneurysm repair at Tufts Medical Center.

The governor said his proposal to regulate pharmacy benefit managers, intermediaries that critics say drive up drug costs, ...

Cytokinetics' PDUFA date for aficamten was extended to December 26th of 2025, due to the FDA's need to review a submitted ...

FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

DBV Technologies faced setbacks, including FDA denial and competition, leading to significant financial losses and stock ...

The U.S. Food and Drug Administration will remove pediatric ingestible fluoride products from the market. The agency cites ...

Red dye No. 3 is now banned in the US -- but it'll take time to phase it out completely. In the meantime, the FDA just ...

This week, we take a closer look at two precedential cases concerning pharmaceutical patent protections as applied to drugs in development.